Health & Biotech
Health & Biotech
Oui oui! MVP buys back Penthrox rights in Europe
Health & Biotech
Victoria’s coronavirus curve tipped to flatten by September: report
Health & Biotech
Aged care operator Estia falls to loss as COVID-19 costs bite
Health & Biotech
The 6 ASX small cap biotechs that have more than doubled in 2020
Health & Biotech
Wellness & Beauty Solutions breaks hand sanitiser news drought with $3m deal
Health & Biotech
Hydrix rolls out ‘heart attack warning system’ into Asian market, shares bounce off lows
Health & Biotech
G Medical to delist from ASX despite a May promise to stay
Health & Biotech
How CardieX is disrupting the last legacy health sector
Health & Biotech
Dr Boreham’s Crucible: Regeneus is now riding the stem cell rollercoaster upwards
Stockhead TV
StockTalk: How are ASX medtechs responding to skyrocketing healthcare spending?
Health & Biotech
MGC Pharma secures UK distributor for its medicinal cannabis treatments
Health & Biotech
Mesoblast caps off rollercoaster week with key tick of approval from US regulators
Health & Biotech
Meluka’s honey flying off the shelves in China
Health & Biotech
Prescient partners with global cancer heavyweight to develop new treatments
Health & Biotech
Health Kick: Zelira’s cannabis-derived insomnia treatment has investors dreaming
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.